We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Digital Device Light Emissions Increase Sleep Dysfunction

By HospiMedica International staff writers
Posted on 09 Aug 2017
Blue light emitted from the screens of electronic devices suppress melatonin by activating intrinsically photosensitive retinal ganglion cells (ipRGCs), according to a new study.

Researchers at the University of Houston (UH, TX, USA) conducted a study in 22 patients in order to investigate whether melatonin level and sleep quality can be modulated by decreasing night-time input to ipRGCs. More...
To do so, study participant wore short-wavelength blocking glasses for an average of three hours prior to bedtime for two weeks. All subjects wore an actigraph device to measure activity, light exposure, and sleep, and saliva samples were collected to assess melatonin content. The Pittsburgh Sleep Quality Index (PSQI) was administered to assess subjective sleep quality.

The ipRGC-mediated post illumination pupil response was measured before and after the experimental period. During measurement, light exposure was presented using a flash electrode ganzfeld stimulator, which included one-second and five-seconds of long and short wavelength light. Pupil diameter was measured before, during, and for 60 seconds following flash stimulation. Six-second and 30-second post illumination pupil response and area under the curve following light offset were then determined.

The results showed that after the experimental period, the pupil exhibited a slower redilation phase, resulting in a significantly increased 30 second post illumination pupil response to the one-second short wavelength light, and decreased area under the curve for both one and five-second short wavelength light, when measured at the same time of day as baseline. Concomitantly, nighttime melatonin levels rose by 58%, objectively measured sleep duration increased by 24 minutes, and the mean PSQI score improved from 5.6 to 3.0. The study was published on June 27, 2017, in Ophthalmic & Physiological Optics.

“The most important takeaway is that blue light at night time really does decrease sleep quality. Sleep is very important for the regeneration of many functions in our body,” said lead author Lisa Ostrin, MD, of the UH College of Optometry. “By using blue blocking glasses we are decreasing input to the photoreceptors, so we can improve sleep and still continue to use our devices. That's nice, because we can still be productive at night.”

Most digital devices such as laptops, cellular phones, and e-book readers provide apps that can reduce or filter out blue light entirely. The apps do nothing during daylight hours, but after sunset place a red overlay on the screen to change its color temperature, canceling out the negative effects of the blue light and decreasing glare. Most eBook readers, which are black and white, have built-in white-on-black or sepia options that are better than a white background.

Related Links:
University of Houston


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.